Diabetes and the global burden of non-communicable disease [4]

Lancet

Volumn 362, Issue 9397, 2003, Pages 1763-1764

  Matthews, David R ^a   Pramming, Stig ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CAUSE OF DEATH; DEATH CERTIFICATE; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE CLASSIFICATION; GOVERNMENT; HEALTH CARE; HEART INFARCTION; HUMAN; INTERNATIONAL COOPERATION; ISCHEMIC HEART DISEASE; LETTER; MORTALITY; PRIORITY JOURNAL; RECORDING; RISK ASSESSMENT; RISK MANAGEMENT; STATISTICAL ANALYSIS;

EID: 0344552416     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14877-5     Document Type: Letter

References (5)

1. Beaglehole R., Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet. 362:2003;903-908.
2. King H., Aubert R.E., Herman W.H. Global burden of diabetes 1995-2025: prevalence, numerical estimates and projections. Diabetes Care. 21:1998;1414-1431.
3. Fuller J.H., Elford J., Goldblatt P., Adelstein A.M. Diabetes mortality: new light on an underestimated public health problem. Diabetologia. 24:1983;336-341.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
5. Zimmet P., Alberti K.G., Shaw J. Global and social implications of the diabetes epidemic. Nature. 414:2001;782-787.